Obicetrapib
Especificaciones
866399-87-3Número CAS
956-870-5Número CE
4-[2-[[3,5-bis(trifluoromethyl)phenyl]methyl-[(2R,4S)-1-ethoxycarbonyl-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinolin-4-yl]amino]pyrimidin-5-yl]oxybutanoic acidNombre IUPAC
C32H31F9N4O5Fórmula química
722.6 g/molPeso molecular
Obicetrapib; 866399-87-3; TA-8995; AMG-899; DEZ-001; 8O74K609HN; 4-[2-[[3,5-bis(trifluoromethyl)phenyl]methyl-[(2R,4S)-1-ethoxycarbonyl-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinolin-4-yl]amino]pyrimidin-5-yl]oxybutanoic acid; (2R,4S)-4-((3,5-Bis(trifluoromethyl)benzyl)(5-(3-carboxypropoxy)pyrimidin-2-yl)amino)-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; 1(2H)-Quinolinecarboxylic acid, 4-(((3,5-bis(trifluoromethyl)phenyl)methyl)(5-(3-carboxypropoxy)-2-pyrimidinyl)amino)-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-ethyl ester, (2R,4S)-; 1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-ethyl ester, (2R,4S)-; 4-{[2-({[3,5-bis(trifluoromethyl)phenyl]methyl}[(2R,4S)-1-(ethoxycarbonyl)-2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl]amino)pyrimidin-5-yl]oxy}butanoic acid; obicetrapibum; (2R,4S)-4-[[3,5-Bis(trifluoromethyl)benzyl][5-(3-carboxypropoxy)pyrimidin-2-yl]amino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; 4-((2-(((3,5-BIS(TRIFLUOROMETHYL)PHENYL)METHYL)((2R,4S)-1-(ETHOXYCARBONYL)-2-ETHYL-6-(TRIFLUOROMETHYL)-1,2,3,4-TETRAHYDROQUINOLIN-4-YL)AMINO)PYRIMIDIN-5-YL)OXY)BUTANOIC ACID; 4-(2-((3,5-bis(trifluoromethyl)phenyl)methyl-((2R,4S)-1-ethoxycarbonyl-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinolin-4-yl)amino)pyrimidin-5-yl)oxybutanoic acid; RefChem:167342; Obicetrapib (free base); Obicetrapib [INN]; 1-Ethyl (2R,4S)-4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylate; 866399-87-3 (free base); CASA; Obicetrapib (USAN/INN); OBICETRAPIB [USAN]; OBICETRAPIB [WHO-DD]; UNII-8O74K609HN; orb1699785; CHEMBL3785197; SCHEMBL17002081; GTPL12205; NRWORBQAOQVYBJ-GJZUVCINSA-N; DTXSID601358925; EX-A6112; TA8995; AKOS032954130; Obicetrapib (AMG-899,TA-8995); DB14890; Obicetrapib (AMG-899,TA-8995)?; 4-((2-((3,5-bis(trifluoromethyl)benzyl)((2R,4S)-1-(ethoxycarbonyl)-2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl)amino)pyrimidin-5-yl)oxy)butanoic acid; AC-35552; HY-18778; TS-08594; D12900; G87131; T28225; Q27270811; 4-((2-(((3,5-Bis(trifluoromethyl)phenyl)methyl)((2R,4S)-1- (ethoxycarbonyl)-2-ethyl-6-(trifluoromethyl)-1,2,3,4- tetrahydroquinolin-4-yl)amino)pyrimidin-5-yl)oxy)butanoic acidSinónimos
